Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart - PubMed (original) (raw)

. 1991 May;343(5):505-10.

doi: 10.1007/BF00169553.

Affiliations

• PMID: 1881461
• DOI: 10.1007/BF00169553

Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart

A Alberola et al. Naunyn Schmiedebergs Arch Pharmacol. 1991 May.

Abstract

The glutathione redox pathway is an important antioxidant system in the myocardium. N-Acetylcysteine is a low molecular weight glutathione precursor that has been used clinically to replenish glutathione stores. The present study was aimed at evaluating the protective effect of N-acetylcysteine on myocardial damage resulting from permanent coronary occlusion (without reperfusion) in anaesthetized dogs. N-Acetylcysteine (150 mg kg-1 i.v.) administered 2 min before occlusion reduced infarct size in dogs subjected to 24 h ischemia. The infarct size as a percentage of the area at risk was 86.8 +/- 3.6% (n = 11) in control (saline-treated) dogs and 68.2 +/- 2.4% (n = 7; P less than 0.05 vs control) in N-acetylcysteine-treated animals. Haemodynamic variables (heart rate, mean arterial pressure and rate-pressure product) were similar in the control and the treated group. Regional myocardial blood flow was determined with radioactive microspheres in ischaemic and non-ischaemic zones before occlusion and 3 h post-occlusion. N-Acetylcysteine did not influence the regional distribution of myocardial blood flow. The myocardial content of reduced glutathione was significantly (P less than 0.05) decreased 3 h post-occlusion (0.53 +/- 0.19 mumol/g-1; n = 5) compared to either pre-occlusion values (0.94 +/- 0.03 mumol/g-1; n = 8) or values 3 h post-occlusion in sham-operated animals (0.93 +/- 0.15 mumol/g-1; n = 5). Depletion of myocardial glutathione 3 h post-occlusion was not observed in dogs treated with N-acetylcysteine (0.87 +/- 0.11 mumol/g-1; n = 5).(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Similar articles

• Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function.
  Forman MB, Puett DW, Cates CU, McCroskey DE, Beckman JK, Greene HL, Virmani R. Forman MB, et al. Circulation. 1988 Jul;78(1):202-13. doi: 10.1161/01.cir.78.1.202. Circulation. 1988. PMID: 3383404
• gamma-Glutamylcysteine ethyl ester for myocardial protection in dogs during ischemia and reperfusion.
  Hoshida S, Kuzuya T, Yamashita N, Nishida M, Kitahara S, Hori M, Kamada T, Tada M. Hoshida S, et al. J Am Coll Cardiol. 1994 Nov 1;24(5):1391-7. doi: 10.1016/0735-1097(94)90125-2. J Am Coll Cardiol. 1994. PMID: 7930265
• N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia.
  Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR. Kehl F, et al. Anesthesiology. 2003 Jun;98(6):1384-90. doi: 10.1097/00000542-200306000-00013. Anesthesiology. 2003. PMID: 12766647
• Effect of N-acetylcysteine on myocardial infarct size following ischemia and reperfusion in dogs.
  Tripathi Y, Hegde BM. Tripathi Y, et al. Indian J Physiol Pharmacol. 1998 Jan;42(1):50-6. Indian J Physiol Pharmacol. 1998. PMID: 9513793
• Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
  Ehring T, Heusch G. Ehring T, et al. Cardiology. 1997;88 Suppl 1:3-14; discussion 15-6. doi: 10.1159/000177451. Cardiology. 1997. PMID: 9118166 Review.

Cited by

• Bioactivity and Therapeutic Potential of Kaempferol and Quercetin: New Insights for Plant and Human Health.
  Jan R, Khan M, Asaf S, Lubna, Asif S, Kim KM. Jan R, et al. Plants (Basel). 2022 Oct 5;11(19):2623. doi: 10.3390/plants11192623. Plants (Basel). 2022. PMID: 36235488 Free PMC article. Review.
• Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia.
  Brown DA, Hale SL, Baines CP, del Rio CL, Hamlin RL, Yueyama Y, Kijtawornrat A, Yeh ST, Frasier CR, Stewart LM, Moukdar F, Shaikh SR, Fisher-Wellman KH, Neufer PD, Kloner RA. Brown DA, et al. J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):121-32. doi: 10.1177/1074248413508003. Epub 2013 Nov 28. J Cardiovasc Pharmacol Ther. 2014. PMID: 24288396 Free PMC article.
• Antioxidant properties of myocardial fuels.
  Mallet RT, Sun J. Mallet RT, et al. Mol Cell Biochem. 2003 Nov;253(1-2):103-11. doi: 10.1023/a:1026009519783. Mol Cell Biochem. 2003. PMID: 14619960 Review.

References

1. 1. J Clin Invest. 1984 Jun;73(6):1772-84 - PubMed
2. 1. Circulation. 1988 Jul;78(1):202-13 - PubMed
3. 1. Biochem J. 1967 Aug;104(2):627-33 - PubMed
4. 1. Circulation. 1971 Jan;43(1):67-82 - PubMed
5. 1. Prog Cardiovasc Dis. 1987 Jul-Aug;30(1):23-44 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information